Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Icatibant Injection, 30 mg/3 mL (10 mg/mL) Single-Dose Prefilled Syringe.".